ACTHIV 2023 CME/CE Information

Please note that all attendees are required to review all CME/CE information provided, as well as the session agenda prior to registering for the conference.

About the Conference

The 17th Annual American Conference for the Treatment of HIV (ACTHIV) is the premier conference in the US dedicated exclusively to members of the frontline team who care for individuals living with HIV or who are at risk of acquiring HIV. The conference delivers information to learners on new developments and research findings that can be rapidly translated and directly applied to the clinical setting.

Target Audience

ACTHIV is targeted toward the members of the frontline team caring for persons with or at risk of acquiring HIV: physicians (both specialists and primary care/family medicine), advanced practice nurses, physician assistants, nurses, pharmacists, and medical case managers.

Other members of the care team, including psychologists, mental health and substance abuse workers, treatment advocates, treatment educators, and researchers, are also encouraged to attend.

Global Conference Objectives / Learning Outcomes

At the conclusion of the conference, learners should be better able to:

  • Review foundational concepts for the care of people living with HIV (PLWH)
  • Apply new insights for optimizing antiretroviral therapy in both treatment naïve and treatment experienced adults
  • Identify strategies for improving the diagnosis and management of hepatitis coinfection and liver disease in PLWH
  • Incorporate best practices for the prevention and management of comorbidities and HIV-related complications in PLWH
  • Identify challenges and opportunities for improving STI and HIV prevention with your care team
  • Analyze evolving opportunities and challenges for the members of the HIV care team


In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.




American Academy of CME, Inc. designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification Credits
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your points will be automatically submitted to the ABIM on your behalf; please allow 6-8 weeks for your points to display on the ABIM website.

CLAIMING MOC POINTS: If you intend to claim MOC points for your participation, you will need to provide your unique, six-digit ABIM ID Number when completing your evaluation. Physicians who do not know their ABIM ID can look it up on ABIM’s website

Family Physicians

The AAFP has reviewed The 16th Annual American Conference for the Treatment of HIV (ACTHIV) and deemed it acceptable for up to 19.00 Live AAFP Prescribed credits. Term of Approval is from 05/05/2022 to 05/07/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners/Nurses:
American Academy of CME, Inc. designates this educational activity for 19.0 ANCC contact hours.

Please check onsite for pharmacotherapeutic contact hours available for each session.

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 19.0 contact hours.

Physician Assistants:
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity provides 19.0 ACPE contact hours (1.90 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-22-001-L02-P, Application.

Your statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacy learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

Other healthcare professionals will receive a certificate of completion.

Conference Fees

Registration for the conference includes continuing education credits.

  • Early Bird Registration (prior to March 1, 2022): $400
  • Standard Price: $500
  • Student/Resident/Fellow Registration (prior to March 1, 2022): $175
  • Standard Price: $275

Disclosure Declaration

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Relevant financial relationships will be made known to the participants prior to the activity.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy or ACTHIV. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.


Supported by educational grants from Gilead Sciences, Janssen Therapeutics, Division of Janssen Products, LP,  Merck, Theratechnologies and ViiV Healthcare. Please check back for updates as additional conference supporters are confirmed.

Please check back for updates as conference supporters are confirmed.


In compliance with the Americans with Disabilities Act of 1990, ACTHIV will make all reasonable efforts to accommodate persons with disabilities. Please contact Debbie Cooke at [email protected] with your request.